Aurobindo Pharma Limited (AUROPHARMA.NS)

INR 1266.0

(1.48%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 450.71 Billion 398.89 Billion 339.21 Billion 338.53 Billion 289.26 Billion 264.54 Billion
Total Current Assets 242.05 Billion 215.45 Billion 181.22 Billion 198.23 Billion 164.12 Billion 153.64 Billion
Cash And Short Term Investments 63.28 Billion 65.25 Billion 45.57 Billion 56.21 Billion 28.42 Billion 19.28 Billion
Cash and Cash Equivalents 62.78 Billion 43.96 Billion 41.62 Billion 53.73 Billion 27.63 Billion 18.55 Billion
Short Term Investments 505.8 Million 21.29 Billion 3.95 Billion 2.47 Billion 784.6 Million 735 Million
Net Receivables 48.35 Billion 46.4 Billion 44.56 Billion 37.26 Billion 43.84 Billion 59.64 Billion
Inventory 98.08 Billion 85.11 Billion 75.53 Billion 90.26 Billion 76.99 Billion 72.45 Billion
Other Current Assets 32.33 Billion 18.68 Billion 15.55 Billion 14.48 Billion 14.85 Billion 2.25 Billion
Total Non-Current Assets 208.65 Billion 183.44 Billion 157.99 Billion 140.3 Billion 125.13 Billion 110.89 Billion
Net PPE 142.84 Billion 124.91 Billion 106.65 Billion 93.15 Billion 81.16 Billion 70.35 Billion
Good Will And Intangible Assets 40.76 Billion 39.21 Billion 36.13 Billion 31.19 Billion 32.65 Billion 31.07 Billion
Good Will 5.95 Billion 5.96 Billion 4.75 Billion 4.28 Billion 9.15 Billion 8.32 Billion
Intangible Assets 34.81 Billion 33.25 Billion 31.37 Billion 26.9 Billion 23.49 Billion 22.75 Billion
Long-Term Investments 6.78 Billion 3.91 Billion 6.18 Billion 4.31 Billion 5.54 Billion 2.88 Billion
Tax Assets 12.12 Billion 6.77 Billion 2.88 Billion 4.52 Billion 1.63 Billion 1.83 Billion
Other Non Current Assets 6.13 Billion 8.61 Billion 6.12 Billion 7.11 Billion 4.13 Billion 4.74 Billion
Other Assets - - - - - -
Total Liabilities 152.2 Billion 130.38 Billion 93.47 Billion 119.25 Billion 121.15 Billion 125.62 Billion
Total Current Liabilities 121.99 Billion 114.93 Billion 81.55 Billion 106.65 Billion 113.86 Billion 120.42 Billion
Account Payables 44.54 Billion 38.71 Billion 27.03 Billion 27.94 Billion 25.45 Billion 26.77 Billion
Tax Payables 2.49 Billion 2.11 Billion 580.3 Million 2.1 Billion 1.28 Billion 662.7 Million
Short Term Debt 42.6 Billion 43.45 Billion 27.11 Billion 51.15 Billion 60.36 Billion 67.86 Billion
Deferred Revenue 2.49 Billion 21.33 Billion 26.13 Billion 26.43 Billion 26.9 Billion 25.34 Billion
Other Current Liabilities 32.35 Billion 11.43 Billion 1.27 Billion 1.11 Billion 1.14 Billion 447.5 Million
Total Non Current Liabilities 30.21 Billion 15.44 Billion 11.91 Billion 12.59 Billion 7.29 Billion 5.19 Billion
Long-Term Debt 21.34 Billion 9.4 Billion 5.67 Billion 4.34 Billion 2.64 Billion 1.79 Billion
Deferred Revenue Non Current 2.52 Billion 17.29 Billion 1.83 Billion 2.11 Billion 747.1 Million 465.4 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 2.77 Billion -15.15 Billion 297.7 Million 395 Million 874.8 Million 113 Million
Other Liabilities - - - - - -
Total Equity 298.5 Billion 268.51 Billion 245.74 Billion 219.28 Billion 168.1 Billion 138.92 Billion
Stock Holders Equity 298.42 Billion 268.39 Billion 245.75 Billion 219.29 Billion 168.1 Billion 138.9 Billion
Common Stock 585.9 Million 585.9 Million 585.9 Million 585.9 Million 585.9 Million 585.9 Million
Retained Earnings 268.01 Billion 240.13 Billion 225.19 Billion 201.36 Billion 150.58 Billion 124.16 Billion
Accumulated other comprehensive income 25.64 Billion 23.5 Billion 15.8 Billion 13.16 Billion 13.05 Billion -17.34 Billion
Common Stock Equity 298.42 Billion 268.39 Billion 245.75 Billion 219.29 Billion 168.1 Billion 138.9 Billion
Capital Lease Obligation 2.52 Billion 4.24 Billion 4.78 Billion 3.66 Billion 3.75 Billion 646 Million
Total Investments 7.29 Billion 5.42 Billion 6.18 Billion 4.31 Billion 6.71 Billion 3.62 Billion
Total Debt 66.47 Billion 52.86 Billion 32.78 Billion 55.49 Billion 63.01 Billion 69.66 Billion
Net Debt 3.69 Billion 8.89 Billion -8.83 Billion 1.76 Billion 35.37 Billion 51.11 Billion

Balance Sheet Charts